Gumintad, Anamae .

HRN: 29-27-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
CEFUROXIME 500MG (TAB)
07/09/2026
07/16/2026
IVT
500 Mg
BID
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines